Thomas Patrick Kelly, Chief Financial Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 10,850 shares at $40.69 ($447K) on 2019-08-13, disclosed to the SEC on 2019-08-13.
Open-market sale of $447k DCPH by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.69 | 7,264 | $296K | 66.1% |
| 2 | $42.25 | 3,586 | $152K | 33.9% |
| Total | $41.21 avg | 10,850 | $447K | 100% |
| Filing → |
| DCPH | SELL | 2023-12-14 | $43K | — | Filing → |
| DCPH | SELL | 2023-10-31 | $28K | — | Filing → |
| DCPH | SELL | 2023-06-21 | $24K | — | Filing → |